Gene · 8318
Papers1,933
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,933
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function. | Mol Cancer Ther | 2024 | 38982858 | PubTator, text mining | PubMed |
| Single-molecule imaging reveals the mechanism of bidirectional replication initiation in metazoa. | Cell | 2024 | 38866019 | PubTator, text mining | PubMed |
| Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment. | Cancer Rep (Hoboken) | 2024 | 38717954 | PubTator, text mining | PubMed |
| A Decade of Discovery-Eukaryotic Replisome Disassembly at Replication Termination. | Biology (Basel) | 2024 | 38666845 | PubTator, text mining | PubMed |
| Replisome Proximal Protein Associations and Dynamic Proteomic Changes at Stalled Replication Forks. | Mol Cell Proteomics | 2024 | 38615877 | PubTator, text mining | PubMed |
| Induction of the human CDC45 gene promoter activity by natural compound trans‑resveratrol. | Mol Med Rep | 2024 | 38577929 | PubTator, text mining | PubMed |
| Starting DNA Synthesis: Initiation Processes during the Replication of Chromosomal DNA in Humans. | Genes (Basel) | 2024 | 38540419 | PubTator, text mining | PubMed |
| Unwinding Helicase MCM Functionality for Diagnosis and Therapeutics of Replication Abnormalities Associated with Cancer: A Review. | Mol Diagn Ther | 2024 | 38530633 | PubTator, text mining | PubMed |
| Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer. | PeerJ | 2024 | 38515458 | PubTator, text mining | PubMed |
| Upregulation of lnc-FOXD2-AS1, CDC45, and CDK1 in patients with primary non-M3 AML is associated with a worse prognosis. | Blood Res | 2024 | 38485838 | PubTator, text mining | PubMed |
| A second hotspot for pathogenic exon-skipping variants in CDC45. | Eur J Hum Genet | 2024 | 38467731 | PubTator, text mining | PubMed |
| The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs. | Mol Cancer Ther | 2024 | 38466804 | PubTator, text mining | PubMed |
| Deciphering the molecular functionality of Cdc45 in replisomal complex. | Biochem Biophys Rep | 2024 | 38298211 | PubTator, text mining | PubMed |
| The ORFIUS complex regulates ORC2 localization at replication origins. | NAR Cancer | 2024 | 38288445 | PubTator, text mining | PubMed |
| Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets. | Int J Mol Sci | 2024 | 38279263 | PubTator, text mining | PubMed |
| The m6A demethylase FTO targets POLQ to promote ccRCC cell proliferation and genome stability maintenance. | J Cancer Res Clin Oncol | 2024 | 38270643 | PubTator, text mining | PubMed |
| A critical threshold of MCM10 is required to maintain genome stability during differentiation of induced pluripotent stem cells into natural killer cells. | Open Biol | 2024 | 38262603 | PubTator, text mining | PubMed |
Unraveling the underlying pathogenic factors driving nonalcoholic steatohepatitis and hepatocellular carcinoma: an in-depth analysis of prognostically relevant gene signatures in hepatocellular carcinoma. | J Transl Med | 2024 | 38238845 | PubTator, text mining | PubMed |
| From structural polymorphism to structural metamorphosis of the coat protein of flexuous filamentous potato virus Y. | Commun Chem | 2024 | 38233506 | PubTator, text mining | PubMed |
| Replication Protein A, the Main Eukaryotic Single-Stranded DNA Binding Protein, a Focal Point in Cellular DNA Metabolism. | Int J Mol Sci | 2024 | 38203759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8318/papers?page=5